Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline

The forthcoming National Institute for Health and Care Excellence depression guideline reviews short-term outcomes for long-term depression. We present effect sizes for long-term outcomes in trials that report these data. Psychological therapies become more effective, whereas antidepressants become...

Descripción completa

Detalles Bibliográficos
Autores principales: McPherson, Susan, Hengartner, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737515/
https://www.ncbi.nlm.nih.gov/pubmed/31685073
http://dx.doi.org/10.1192/bjo.2019.65
_version_ 1783450670698856448
author McPherson, Susan
Hengartner, Michael P.
author_facet McPherson, Susan
Hengartner, Michael P.
author_sort McPherson, Susan
collection PubMed
description The forthcoming National Institute for Health and Care Excellence depression guideline reviews short-term outcomes for long-term depression. We present effect sizes for long-term outcomes in trials that report these data. Psychological therapies become more effective, whereas antidepressants become less effective over the long term. We review other forms of longitudinal research that support these findings. DECLARATION OF INTEREST: None.
format Online
Article
Text
id pubmed-6737515
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-67375152019-09-17 Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline McPherson, Susan Hengartner, Michael P. BJPsych Open Commentary The forthcoming National Institute for Health and Care Excellence depression guideline reviews short-term outcomes for long-term depression. We present effect sizes for long-term outcomes in trials that report these data. Psychological therapies become more effective, whereas antidepressants become less effective over the long term. We review other forms of longitudinal research that support these findings. DECLARATION OF INTEREST: None. Cambridge University Press 2019-09-09 /pmc/articles/PMC6737515/ /pubmed/31685073 http://dx.doi.org/10.1192/bjo.2019.65 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
McPherson, Susan
Hengartner, Michael P.
Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title_full Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title_fullStr Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title_full_unstemmed Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title_short Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
title_sort long-term outcomes of trials in the national institute for health and care excellence depression guideline
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737515/
https://www.ncbi.nlm.nih.gov/pubmed/31685073
http://dx.doi.org/10.1192/bjo.2019.65
work_keys_str_mv AT mcphersonsusan longtermoutcomesoftrialsinthenationalinstituteforhealthandcareexcellencedepressionguideline
AT hengartnermichaelp longtermoutcomesoftrialsinthenationalinstituteforhealthandcareexcellencedepressionguideline

Ejemplares similares